Based on the earnings transcript, American Express Company's results for the second quarter of 2015 show solid core earnings performance despite some headwinds. The company's revenue growth was 5% after adjusting for FX and the prior year impact of Business Travel revenues, and EPS was relatively consistent with the prior year. However, the company expects earnings per share for the second half of the year to be down versus the prior year, consistent with their discussions on Investor Day. The company also expects their full year 2015 EPS outlook to remain unchanged, with EPS growth expected to be flat to modestly down. The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%.

The company's spending on incremental growth initiatives is expected to be more concentrated in the second half of the year, and the company believes that their outlook for 2016 and 2017 remains appropriate. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's financial results for the second quarter show that reported billings growth was 2% on an FX-adjusted basis, with growth in the U.S. slowing to 5% from 6% in the first quarter. The company's international regions saw strong growth in JAPA, with growth of 16% on an FX-adjusted basis. The company also saw improved performance in EMEA, with growth in the U.K. remaining in the double digits. The company's reported revenue growth was down 4% due to the inclusion of Business Travel revenues in the prior year and the stronger U.S. dollar. Excluding these items, adjusted revenue growth was 5%.

The company's net income was down 4% versus the prior year, with the decline primarily driven by the net benefit related to the Business Travel joint venture transaction and Business Travel operating income in Q2 '14. The company also made its first preferred dividend payment during the second quarter, which reduced EPS by approximately $0.02.

The company's return on equity (ROE) was 28% for the period ended June 30, well above their on-average and overtime target of 25%. The company's capital performance shows that the company returned 97% of the capital it generated to shareholders while maintaining its strong capital ratios.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

The company's outlook for 2016 and 2017 remains appropriate, with EPS growth expected to be within their target range of 12% to 15%. The company's outlook for 2016 and 2017 does not contemplate the impact of any restructuring charges or other contingencies.

